The First Affiliated Hospital of Xiamen University
π¨π³China
Prospective Clinical Study of Orelabrutinib in Combination With Rituximab (OR) for Primary Marginal Zone Lymphoma (MZL) That Failed or Not Suitable for Local Therapy
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-06-27
- Last Posted Date
- 2024-07-29
- Target Recruit Count
- 36
- Registration Number
- NCT06478472
- Locations
- π¨π³
Bing, Xu, Xiamen, Fujian, China
ImmunoPET Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) in Thyroid Cancer
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-06-18
- Last Posted Date
- 2024-06-18
- Target Recruit Count
- 90
- Registration Number
- NCT06465017
- Locations
- π¨π³
The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
A Study of Paclitaxel Combined With Apatinib and Adebrelimab in Gastric/Gastroesophageal Junction Adenocarcinoma
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-05-16
- Last Posted Date
- 2024-05-29
- Target Recruit Count
- 30
- Registration Number
- NCT06415669
- Locations
- π¨π³
The First Affiliated Hospital of Xiamen University, Fuzhou, Fujian, China
Genomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO)
- First Posted Date
- 2024-04-26
- Last Posted Date
- 2024-04-26
- Target Recruit Count
- 40
- Registration Number
- NCT06387056
- Locations
- π¨π³
The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
To Assess The Patient Preference for Goserelin Microsphere Versus Goserelin Implant in Patients With Prostate Cancer
- First Posted Date
- 2024-04-26
- Last Posted Date
- 2024-04-26
- Target Recruit Count
- 60
- Registration Number
- NCT06385847
- Locations
- π¨π³
The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
Effect of Oliceridine on Rebound Pain
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-04-24
- Last Posted Date
- 2024-04-25
- Target Recruit Count
- 320
- Registration Number
- NCT06382896
- Locations
- π¨π³
First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
Clinical Evaluation of 177Lu-DansyI-PSMA (LNC1011) in Patients With Metastatic Castration-Resistant Prostate Cancer
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-04-22
- Last Posted Date
- 2024-04-22
- Target Recruit Count
- 20
- Registration Number
- NCT06377683
- Locations
- π¨π³
The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
Clinical Evaluation of 177Lu-AB-3PRGD2 in Various Solid Tumors With Integrin Ξ±vΞ²3 Positive Expression
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-04-19
- Last Posted Date
- 2024-06-17
- Target Recruit Count
- 20
- Registration Number
- NCT06375564
- Locations
- π¨π³
The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
Dexmedetomidine Premedication for Post-anaesthesia Sleep Disturbance
Phase 3
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-02-28
- Last Posted Date
- 2024-04-16
- Target Recruit Count
- 110
- Registration Number
- NCT06281561
Application of Augmented Reality Neuronavigation in Transnasal Endoscopic Skull Base Surgery
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-02-28
- Last Posted Date
- 2024-09-30
- Target Recruit Count
- 10
- Registration Number
- NCT06282224
- Locations
- π¨π³
The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
Β© Copyright 2024. All Rights Reserved by MedPath